Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes (original) (raw)

References

  1. Defronzo RA . Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 2004; 88: 787–835.
    Article CAS Google Scholar
  2. Unger RH . Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003; 144: 5159–5165.
    Article CAS Google Scholar
  3. Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, Defronzo RA . Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 2004; 47: 31–39.
    Article CAS Google Scholar
  4. Polonsky KS, Gumbiner B, Ostrega D, Griver K, Tager H, Henry RR . Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM. Diabetes 1994; 43: 871–877.
    Article CAS Google Scholar
  5. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724–1737.
    Article CAS Google Scholar
  6. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683–2693.
    Article Google Scholar
  7. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006; 244: 741–749.
    Article Google Scholar
  8. Cummings DE, Overduin J, Foster-Schubert KE . Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 2004; 89: 2608–2615.
    Article CAS Google Scholar
  9. Dixon JB, O’Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008; 299: 316–323.
    CAS Google Scholar
  10. Korner J, Inabnet W, Conwell IM, Taveras C, Daud A, Olivero-Rivera L et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity (Silver Spring) 2006; 14: 1553–1561.
    Article CAS Google Scholar
  11. Korner J, Inabnet W, Febres G, Conwell IM, McMahon DJ, Salas R et al. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y bypass. Int J Obes 2009; 33: 786–795.
    Article CAS Google Scholar
  12. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339–350.
    Article CAS Google Scholar
  13. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467–484.
    PubMed PubMed Central Google Scholar
  14. Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 2004; 240: 236–242.
    Article Google Scholar
  15. Goldfine AB, Mun EC, Devine E, Bernier R, Baz-Hecht M, Jones DB et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab 2007; 92: 4678–4685.
    Article CAS Google Scholar
  16. Korner J, Bessler M, Inabnet W, Taveras C, Holst JJ . Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis 2007; 3: 597–601.
    Article Google Scholar
  17. Laferrere B, Heshka S, Wang K, Khan Y, McGinty J, Teixeira J et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007; 30: 1709–1716.
    Article CAS Google Scholar
  18. Vollmer K, Holst JJ, Baller B, Ellrichmann M, Nauck MA, Schmidt WE et al. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes 2008; 57: 678–687.
    Article CAS Google Scholar
  19. Vidal J, Nicolau J, Romero F, Casamitjana R, Momblan D, Conget I et al. Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects. J Clin Endocrinol Metab 2009; 94: 884–891.
    Article CAS Google Scholar
  20. Burguera B, Agusti A, Arner P, Baltasar A, Barbe F, Barcelo A et al. Critical assessment of the current guidelines for the management and treatment of morbidly obese patients. J Endocrinol Invest 2007; 30: 844–852.
    Article CAS Google Scholar
  21. Defronzo RA, Tobin J, Andres R . Glucose clamp technique: a method for quantifying insulin secretion and insulin resistance. Am J Physiol 1979; 237: E214–E223.
    CAS PubMed Google Scholar
  22. O’Brien PE, Dixon JB, Laurie C, Anderson M . A prospective randomized trial of placement of the laparoscopic adjustable gastric band: comparison of the perigastric and pars flaccida pathways. Obes Surg 2005; 15: 820–826.
    Article Google Scholar
  23. Roa PE, Kaidar-Person O, Pinto D, Cho M, Szomstein S, Rosenthal RJ . Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg 2006; 16: 1323–1326.
    Article Google Scholar
  24. Van CE, Mestrez F, Sturis J, Polonsky KS . Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 1992; 41: 368–377.
    Article Google Scholar
  25. Guidone C, Manco M, Valera-Mora E, Iaconelli A, Gniuli D, Mari A et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006; 55: 2025–2031.
    Article CAS Google Scholar
  26. Troy S, Soty M, Ribeiro L, Laval L, Migrenne S, Fioramonti X et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab 2008; 8: 201–211.
    Article CAS Google Scholar
  27. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 2002; 51: 2796–2803.
    Article CAS Google Scholar
  28. Salinari S, Bertuzzi A, Asnaghi S, Guidone C, Manco M, Mingrone G . First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care 2009; 32: 375–380.
    Article CAS Google Scholar
  29. Kirwan JP, Kohrt WM, Wojta DM, Bourey RE, Holloszy JO . Endurance exercise training reduces glucose-stimulated insulin levels in 60- to 70-year-old men and women. J Gerontol 1993; 48: M84–M90.
    Article CAS Google Scholar
  30. Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Jarvinen H . Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterology 2008; 135: 122–130.
    Article CAS Google Scholar
  31. Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, Alexandrides TK . Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes 2003; 52: 1098–1103.
    Article CAS Google Scholar
  32. Guijarro A, Suzuki S, Chen C, Kirchner H, Middleton FA, Nadtochiv S et al. Characterization of weight loss and weight regain mechanisms following Roux-en-Y gastric bypass in rats. Am J Physiol Regul Intreg Comp Physiol 2007; 293: 1474–1489.
    Article Google Scholar
  33. Johansson L, Roos M, Kullberg J, Weis J, Ahlstrom H, Sundbom M et al. Lipid mobilization following Roux-en-Y gastric bypass examined by magnetic resonance imaging and spectroscopy. Obes Surg 2008; 18: 1297–1304.
    Article CAS Google Scholar
  34. Bikman BT, Zheng D, Pories WJ, Chapman W, Pender JR, Bowden RC et al. Mechanism for improved insulin sensitivity after gastric bypass surgery. J Clin Endocrinol Metab 2008; 93: 4656–4663.
    Article CAS Google Scholar
  35. Mingrone G, DeGaetano A, Greco AV, Capristo E, Benedetti G, Castagneto M et al. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia 1997; 40: 599–605.
    Article CAS Google Scholar
  36. Phillips ML, Lewis MC, Chew V, Kow L, Slavotinek JP, Daniels L et al. The early effects of weight loss surgery on regional adiposity. Obes Surg 2005; 15: 1449–1455.
    Article Google Scholar
  37. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 2005; 11: 90–94.
    Article CAS Google Scholar

Download references